Resolian, a leading global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials, announced several leadership changes as the company expands...
DELFI Diagnostics, Inc., developer of accessible blood-based liquid biopsy tests that deliver a new way to enhance early cancer detection, is announcing the appointment...
AbbVie and Aliada Therapeutics announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology company advancing therapies using a novel blood-brain barrier...
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing...
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced the launch of its EXpressCTSM (Expression Signatures Through Circulating Tumor Signals) liquid biopsy platform...
